Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart DiseaseInsights from ENGAGE AF-TIMI 48

被引：1
|
作者：
Owens, Ryan E. [1 ]
Kabra, Rajesh [2 ]
Oliphant, Carrie S. [3 ]
机构：
[1] Univ Oklahoma, Coll Pharm, Dept Pharm Clin & Adm Sci, Oklahoma City, OK 73106 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med, Div Cardiol, Memphis, TN 38163 USA
[3] Univ Tennessee, Coll Pharm, Methodist Univ Hosp, Dept Clin Pharm, Memphis, TN USA
来源：
CLINICAL CARDIOLOGY | 2017年 / 40卷 / 08期
关键词：
Valvular heart disease; Arrhythmia; all; management; WARFARIN;
D O I：
10.1002/clc.22690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 50 条
  • [1] Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
    De Caterina, Raffaele
    Renda, Giulia
    Carnicelli, Anthony P.
    Nordio, Francesco
    Trevisan, Marco
    Mercuri, Michele F.
    Ruff, Christian T.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1372 - 1382
  • [2] First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trial
    Steffel, Jan
    Ruff, Christian T.
    Hamershock, Rose A.
    Murphy, Sabina A.
    Senior, Roxy
    Roy, Denis
    Lanz, Hans-Joachim
    Mercuri, Michele F.
    Antman, Elliott M.
    Giugliano, Robert P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 244 : 192 - 195
  • [3] Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
    Kato, Eri Toda
    Giugliano, Robert P.
    Ruff, Christian T.
    Koretsune, Yukihiro
    Yamashita, Takeshi
    Kiss, Robert Gabor
    Nordio, Francesco
    Murphy, Sabina A.
    Kimura, Tetsuya
    Jin, James
    Lanz, Hans
    Mercuri, Michele
    Braunwald, Eugene
    Antman, Elliott M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05):
  • [4] Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
    Magnani, Giulia
    Giugliano, Robert P.
    Ruff, Christian T.
    Murphy, Sabina A.
    Nordio, Francesco
    Metra, Marco
    Moccetti, Tiziano
    Mitrovic, Veselin
    Shi, Minggao
    Mercuri, Michele
    Antman, Elliott M.
    Braunwald, Eugene
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (09) : 1153 - 1161
  • [5] Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
    Giugliano, Robert P.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Nordio, Francesco
    Murphy, Sabina A.
    Kappelhof, Johannes A. N.
    Shi, Minggao
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08) : 850 - +
  • [6] Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation The ENGAGE AF-TIMI 48 Trial
    Corbalan, Ramon
    Carlos Nicolau, Jose
    Lopez-Sendon, Jose
    Garcia-Castillo, Armando
    Botero, Rodrigo
    Sotomora, Gustavo
    Horna, Manuel
    Ruff, Christian T.
    Hamershock, Rose A.
    Grip, Laura T.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : 1466 - 1475
  • [7] Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48
    Zelniker, Thomas A.
    Ruff, Christian T.
    Wiviott, Stephen D.
    Blanc, Jean-Jacques
    Cappato, Riccardo
    Nordio, Francesco
    Mercurio, Michele F.
    Lanz, Hans
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2019, 8 (02) : 176 - 185
  • [8] Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF-TIMI 48 Trial
    Fanola, Christina L.
    Ruff, Christian T.
    Murphy, Sabina A.
    Jin, James
    Duggal, Anil
    Babilonia, Noe A.
    Sritara, Piyamitr
    Mercuri, Michele F.
    Kamphuisen, Pieter W.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (16):
  • [9] Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial
    Krekels, Elke H. J.
    Niebecker, Ronald
    Karlsson, Mats O.
    Miller, Raymond
    Shimizu, Takako
    Karlsson, Kristin E.
    Ruff, Christian T.
    Simonsson, Ulrika S. H.
    Jonsson, Siv
    CLINICAL PHARMACOKINETICS, 2016, 55 (09) : 1079 - 1090
  • [10] Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial
    Patel, Siddharth M.
    Palazzolo, Michael G.
    Murphy, Sabina A.
    Antman, Elliot M.
    Braunwald, Eugene
    Lanz, Hans Joachim
    Lip, Gregory Y. H.
    Giugliano, Robert P.
    Ruff, Christian T.
    EUROPACE, 2022, 24 (11): : 1730 - 1738
12345